Turim 21 Investimentos’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-1,230
| Closed | -$29.8K | – | 133 |
|
|
2025
Q2 | $29.8K | Hold |
1,230
| – | – | 0.01% | 60 |
|
|
2025
Q1 | $31.2K | Sell |
1,230
-1,296
| -51% | -$33.9K | 0.01% | 54 |
|
|
2024
Q4 | $67K | Buy |
2,526
+1,296
| +105% | +$35.2K | 0.02% | 47 |
|
|
2024
Q3 | $35.6K | Hold |
1,230
| – | – | 0.01% | 53 |
|
|
2024
Q2 | $34.4K | Hold |
1,230
| – | – | 0.01% | 51 |
|
|
2024
Q1 | $34.1K | Hold |
1,230
| – | – | 0.01% | 48 |
|
|
2023
Q4 | $35.4K | Hold |
1,230
| – | – | 0.01% | 57 |
|
|
2023
Q3 | $40.8K | Hold |
1,230
| – | – | 0.02% | 50 |
|
|
2023
Q2 | $45.1K | Hold |
1,230
| – | – | 0.02% | 53 |
|
|
2023
Q1 | $50.2K | Hold |
1,230
| – | – | 0.05% | 35 |
|
|
2022
Q4 | $63K | Hold |
1,230
| – | – | 0.03% | 35 |
|
|
2022
Q3 | $54K | Sell |
1,230
-10,286
| -89% | -$500K | 0.05% | 40 |
|
|
2022
Q2 | $604K | Hold |
11,516
| – | – | 0.52% | 19 |
|
|
2022
Q1 | $596K | Hold |
11,516
| – | – | 0.26% | 26 |
|
|
2021
Q4 | $680K | Buy |
11,516
+8,100
| +237% | +$401K | 0.3% | 17 |
|
|
2021
Q3 | $147K | Hold |
3,416
| – | – | 0.07% | 39 |
|
|
2021
Q2 | $134K | Buy |
+3,416
| New | +$133K | 0.04% | 54 |
|
|
2021
Q1 | – | Sell |
-1,230
| Closed | -$45K | – | 151 |
|
|
2020
Q4 | $45K | Sell |
1,230
-66
| -5% | -$2.42K | 0.23% | 45 |
|
|
2020
Q3 | $45K | Hold |
1,296
| – | – | 0.05% | 43 |
|
|
2020
Q2 | $40K | Hold |
1,296
| – | – | 0.04% | 25 |
|
|
2020
Q1 | $40K | Hold |
1,296
| – | – | 0.08% | 22 |
|
|
2019
Q4 | $48K | Hold |
1,296
| – | – | 0.03% | 16 |
|
|
2019
Q3 | $44K | Hold |
1,296
| – | – | 0.02% | 16 |
|
|
2019
Q2 | $53K | Hold |
1,296
| – | – | 0.02% | 17 |
|
|
2019
Q1 | $52K | Hold |
1,296
| – | – | 0.03% | 18 |
|
|
2018
Q4 | $54K | Hold |
1,296
| – | – | 0.01% | 20 |
|
|
2018
Q3 | $54K | Sell |
1,296
-770
| -37% | -$29.6K | 0.02% | 21 |
|
|
2018
Q2 | $71K | Hold |
2,066
| – | – | 0.04% | 20 |
|
|
2018
Q1 | $70K | Hold |
2,066
| – | – | 0.02% | 25 |
|
|
2017
Q4 | $71K | Hold |
2,066
| – | – | 0.03% | 22 |
|
|
2017
Q3 | $70K | Buy |
+2,066
| New | +$66.4K | 0.02% | 20 |
|
Other funds holding PFE
Turim 21 Investimentos's PFE Position: Q3 2025 in Review
Turim 21 Investimentos sold out of Pfizer (PFE) in Q3 2025, closing a stake of 1,230 shares — an estimated $29.8K sold.
Turim 21 Investimentos first reported a position in PFE in Q3 2017 and held it in 31 quarters. The position peaked at $680K in Q4 2021. 2,817 funds tracked by Wall St. Rank hold PFE as of Q3 2025.
- Turim 21 Investimentos reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
- Turim 21 Investimentos sold 1,230 Pfizer shares in Q3 2025, an estimated $29.8K.
- Turim 21 Investimentos first reported a position in Pfizer in Q3 2017 and held it in 31 quarters.
- Turim 21 Investimentos's Pfizer position peaked at $680K in Q4 2021.
- 2,817 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.
Based on Turim 21 Investimentos's 13F filing for Q3 2025, filed 14 Nov 2025.